AcquisitionFinTech
XOMA Royalty Corporation acquired Generation Bio Co
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
XOMA Royalty Corporation -> Generation Bio Co · $4.2913 per share
To acquire Generation Bio's cell-targeted lipid nanoparticle delivery platform and potential milestone and royalty payments from Moderna collaboration.
Open source record (SEC) ↗